Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.05
-0.01 (-0.20%)
Dec 5, 2025, 4:00 PM EST - Market closed
Taysha Gene Therapies Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,383 | 355 | 331 | 141 | 448 | 1,002 | |
| Market Cap Growth | 218.38% | 7.14% | 134.50% | -68.52% | -55.28% | - | |
| Enterprise Value | 1,155 | 260 | 227 | 170 | 314 | 724 | |
| Last Close Price | 5.05 | 1.73 | 1.77 | 2.26 | 11.65 | 26.54 | |
| PS Ratio | 238.08 | 42.55 | 21.42 | 56.40 | - | - | |
| PB Ratio | 6.32 | 4.96 | 4.42 | 148.70 | 4.70 | 3.99 | |
| P/TBV Ratio | 6.32 | 4.96 | 4.42 | 148.70 | 4.70 | 3.99 | |
| EV/Sales Ratio | 183.05 | 31.19 | 14.67 | 67.98 | - | - | |
| Debt / Equity Ratio | 0.32 | 0.89 | 0.82 | 63.15 | 0.66 | - | |
| Asset Turnover | 0.03 | 0.05 | 0.10 | 0.02 | - | - | |
| Quick Ratio | 10.39 | 5.30 | 3.92 | 1.40 | 2.88 | 35.24 | |
| Current Ratio | 10.48 | 5.42 | 4.08 | 1.54 | 3.08 | 36.17 | |
| Return on Equity (ROE) | -64.93% | -121.94% | -294.04% | -344.67% | -100.68% | -47.79% | |
| Return on Assets (ROA) | -25.70% | -32.51% | -29.84% | -46.30% | -45.80% | -20.76% | |
| Return on Capital (ROIC) | -29.02% | -39.93% | -45.31% | -71.82% | -52.85% | -21.40% | |
| Return on Capital Employed (ROCE) | -35.50% | -64.60% | -52.50% | -198.50% | -106.80% | -17.10% | |
| Earnings Yield | -7.22% | -25.19% | -33.71% | -117.64% | -38.94% | -5.99% | |
| FCF Yield | -6.16% | -23.02% | -23.23% | -77.25% | -29.53% | -3.07% | |
| Buyback Yield / Dilution | -26.22% | -115.41% | -164.20% | -16.74% | -113.13% | -83.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.